己酉添加衍义
序例上韩保升云∶按药有玉石、草木、虫兽,直云本草者,为诸药中草类最多也。
旧说《本草经》神农所作,而不经见,《汉书·艺文志》亦无录焉。《平帝纪》云∶元始
五
经、本草、方术数十万言。本草之名,盖见于此。而英公李世绩等注引班固叙《黄帝内外经
》云∶本草石之寒温,原疾病之深浅,此乃论经方之语,而无本草之名。唯梁《七录》载《
神农本草》三卷,推以为始,斯为失矣。或疑其间所载生出郡县,有后汉地名者,以为似张
仲景、华佗辈所为,是又不然也。《淮南子》云∶神农尝百草之滋味,一日而七十毒,由是
医方兴焉。盖上世未着文本,师学相传,谓之本草。两汉以来,名医益众,张机、华佗辈,
始因古学,附以新说,通为编述,本草繇是见于经录。然旧经才三卷,药只三百六十五种,
至梁·陶隐居,又进名医别录,亦三百六十五种,因而注释,分为七卷。唐显庆中,监守卫
长史苏恭,又摭其差谬,表请刊定,乃命司空英国公李世绩等,与恭参考得失,又增一百一
十
四种,分门部类,广为二十卷,世谓之《唐本草》。国朝开宝中,两诏医工刘翰、道士马志
等
,相与撰集;又取医家尝用有效者一百三十三种,而附益之;仍命翰林学士卢多逊、李肪、
王、扈蒙等,重为刊定,乃有详定、重定之目,并镂板摹行。由此,医者用药,遂知适从
。而伪蜀孟昶,亦尝命其学士韩保升等,以唐本图经,参比为书,稍或增广,世谓之《蜀本
草》,今亦传行。是书自汉迄今,甫千岁,其间三经撰着,所增药六百余种,收采弥广,可
谓大备。而知医者,犹以为传行既久,后来讲求,浸多参校;近之所用,颇亦漏略,宜有纂
录,以备颐生驱疾之用。嘉 二年八月,有诏(臣)禹锡、(臣)亿、(臣)颂、(臣)洞等,
再加
校正。(臣)等亦既被命,遂更研核。窃谓前世医工,原诊用药,随效辄记,遂至增多。概
见
诸方,浩博难究;虽屡加删定,而去取非一。或《本经》已载,而所述粗略;或俚俗尝用,
而太医未闻,向非因事详着,则遗散多矣。乃请因其疏捂,更为补注。应诸家医书、药谱所
载物品功用,并从采掇;唯名近迂僻,类乎怪诞,则所不取。自余经史百家,虽非方饵之急
,其间或有参说,药验较然可据者,亦兼收载,务从该洽,以副诏意。凡名本草者非一家,
今以《开宝重定》本为正;其分布卷类、经注杂糅、间以朱墨,并从旧例,不复厘改。凡补
注并据诸书所说,其意义与旧文相参者,则从删削,以避重复;其旧已着见,而意有未完,
后书复言,亦具存之,欲详而易晓;仍每条并以朱书其端云∶“(臣)等谨按某书云”某事
;
其别立条者,则解于其末,云“见某书”。凡所引书,以唐、蜀二本草为先,他书则以所着
先后为次第。凡书旧名本草者,今所引用,但着其所作人名曰“某人”,唯唐、蜀本则曰“
唐本云”、“蜀本云”。凡字朱、墨之别,所谓《神农本经》者以朱字;名医因《神农》旧
条而有增补者,以墨字间于朱字;余所增者,皆别立条,并以墨字。凡陶隐居所进者,谓之
《名医别录》,并以其注附于末。凡显庆所增者,亦注其末曰“唐本先附”。凡开宝所增者
,亦注其末曰“今附”。凡今所增补,旧经未有者,于逐条后开列云“新补”。凡药旧分上
中下三品,今之“新补”,难于详辨,但以类附见,如绿矾次于矾石,山姜花次于豆蔻,扶
次于水杨之类是也。凡药有功用,《本经》未见,而旧注已曾引据,今之所增,但涉相
类,更不立条,并附本注之末曰“续注”,如地衣附于垣衣,燕覆附于通草,马藻附于海藻
之类是也。凡旧注出于陶氏者曰“陶隐居云”;出于显庆者,曰“唐本注”;出于开宝者,
曰“今注”;其开宝考据传记者,别曰“今按”、“今详”、“又按”,皆以朱字别于其端
。凡药名《本经》已见而功用未备,今有所益者,亦附于本注之末。凡药有今世已尝用,而
诸书未见,无所辨证者,如葫芦巴、海带之类,则请从太医众论参议,别立为条,曰“新定
”。旧药九百八十三种;新补八十二种,附于注者不预焉;新定一十七种。总新、旧一千八
十二条,皆随类粗释。推以十五凡,则补注之意可见矣。旧着开宝、英公、陶氏三序,皆有
义例,所不可去,仍载于首篇云。
新旧药合一千八十二种
三百六十种神农本经
一百八十二种名医别录
一百一十四种唐本先附
一百三十三种今附
一百九十四种有名未用
八十二种新补
一十七种新定
己酉年(1073年)添加《本草衍义》。
序例上:韩保升说:查考药物分为玉石、草木、虫兽类,直接称为“本草”,是因为在各类药物中草类最多。
旧时说《神农本草经》是神农所作,但并无确凿证据,《汉书·艺文志》也没有收录它。《汉书·平帝纪》记载:“元始年间,五经、本草、方术等著作数十万字。”“本草”之名,大概见于此处。而英国公李世绩等人的注释引用班固叙述《黄帝内经》的话说:“根据药物的寒温属性,探究疾病的深浅程度。”这本来是论述经方的话语,并没有出现“本草”这个名称。只有梁朝《七录》记载有《神农本草》三卷,推崇它为开端,这是错误的。有人怀疑其中记载的出产郡县,有后汉的地名,认为像是张仲景、华佗等人所写,这又不对了。《淮南子》说:“神农品尝百草的味道,一天之内中毒七十次,因此医方兴起。”大概是上古时代没有文字记录,师徒口耳相传,所以称为本草。两汉以来,名医越来越多,张机(字仲景)、华佗等人,才开始依据古代学问,附上新的见解,通盘编纂叙述,本草从此才见于经典目录。然而旧的本草经只有三卷,药物仅三百六十五种,到了梁朝的陶弘景(号隐居),又进献名医的《别录》,也是三百六十五种,于是加以注释,分为七卷。唐高宗显庆年间,监守卫长史苏恭,又搜集其中的差错谬误,上表请求刊正审定,于是命令司空英国公李世绩等人,与苏恭参考得失,又增加一百一十四种,分门别类,扩充为二十卷,世人称之为《唐本草》。本朝开宝年间,两次下诏命医官刘翰、道士马志等人,共同编撰集录;又选取医家常用且有效的药物一百三十三种,附加进去;仍命翰林学士卢多逊、李昉、王祐、扈蒙等人,重新进行刊定审定,于是有了详定、重定的名目,并雕版印刷发行。由此,医生用药,便知道该遵循什么标准。而伪蜀国的孟昶,也曾命令他的学士韩保升等人,以唐代本草图经为参照编写书籍,稍微有所增广,世人称之为《蜀本草》,现在也流传于世。这本书从汉代到现在,刚满一千年,期间三次撰写著述,所增加的药物六百多种,采集范围更加广泛,可以说是非常完备了。但是懂医术的人,仍然认为它流传已久,后来研究探讨,逐渐有很多参校内容;近代所使用的药物,颇为遗漏简略,应该有纂辑记录,以备养生驱除疾病之用。嘉祐二年八月,有诏令臣禹锡、臣亿、臣颂、臣洞等人,再次进行校正。臣等既然接受命令,于是进一步研究考核。私下认为前世的医工,诊察病情用药,随有效就记录,导致数量增多。概览各种药方,浩繁博大难以穷尽;虽然多次加以删减审定,但去留标准不一。有的《本经》已经记载,但描述粗略;有的民间俗用,但太医未曾听闻,如果不是因事详细著录,那么遗失散失的就很多了。于是请求依据其疏漏之处,再行补充注释。凡是各家医书、药谱所载物品的功用,都一并采纳收集;只是名称近于迂腐偏僻,类似怪诞不经的,就不予采纳。其余经过史书百家,虽然不是方剂饵药的急需之物,其中如果有参证说明,药效验证确实有据可查的,也兼收并蓄,务必追求全面洽当,以符合诏书心意。大凡名为本草的并非只有一家,现在以《开宝重定本草》为正统;其分布卷类、经注混杂、间杂朱墨双色,都依照旧例,不再厘清改动。凡是补注都依据诸书所说,如果意义与旧文相重复的,就予以删削,以避免重复;如果旧文已经存在,但意思不完整,后来的书又提到,也全部保存下来,想要详尽而易于理解;每条开头都用红字写着:“臣等谨按某书说”某事;如果是另立条目的,则在末尾解释,写“见某书”。凡是所引用的书,以唐、蜀两代本草为先,其他书则按照著述先后为次序。凡是书中旧名本草的,现在所引用的,只标注其作者人名说“某人”,唯独唐、蜀本则说“唐本说”、“蜀本说”。凡是字色朱、墨的区别,所谓《神农本经》的内容用红字;名医依据《神农》旧条而有增补的,用黑字夹杂在红字之间;其余所增加的,都另立条目,并用黑字。凡是陶弘景所进献的,称为《名医别录》,并将其注释附在末尾。凡是显庆年间所增加的,也在末尾注释说“唐本先附”。凡是开宝年间所增加的,也在末尾注释说“今附”。凡是现在所增补的,旧经中没有的,在逐条后面开列说“新补”。凡是药物旧分上、中、下三品,现在的“新补”,难以详细辨别,只是按类别附在后面,比如绿矾排在矾石之后,山姜花排在豆蔻之后,扶桑排在水杨之类的是这样。凡是药物有功用,《本经》未见,而旧注曾经引用依据,现在所增加的,只要涉及相似类的,不再另立条目,都附在本注的末尾说“续注”,比如地衣附于垣衣,燕覆附于通草,马藻附于海藻之类的是这样。凡是旧注出于陶氏的曰“陶隐居说”;出于显庆年间的,曰“唐本注”;出于开宝年间的,曰“今注”;其中开宝年间考证依据传记者,另外曰“今按”、“今详”、“又按”,都用红字在开头区别开来。凡是药名《本经》已见而功用未完备,现在有所增益的,也附在本注的末尾。凡是药物有当今世人已曾使用,而诸书未见,无所辨证的,比如葫芦巴、海带之类,则请从太医众人的议论参议,另立为条目,曰“新定”。旧药九百八十三种;新补八十二种,附于注的不计算在内;新定一十七种。总计新、旧一千零八十二条,都随类别粗略解释。推究这十五条凡例,补注的意思就可以看见了。旧作的开宝、英公、陶氏三篇序言,都有义理体例,不可去除,仍载于首篇。
新旧药物合计一千零八十二种
三百六十种 神农本经
一百八十二种 名医别录
一百一十四种 唐本先附
一百三十三种 今附
一百九十四种 有名未用
八十二种 新补
一十七种 新定
Added in the Jiyou year (1073): *Bencao Yanyi* (Treatise on Materia Medica).
Preface to the General Principles, Part I: Han Baosheng states: Examining the drugs, they are categorized into minerals (stones and jades), plants (grasses and trees), and animals (insects and beasts). They are directly called "Bencao" (Materia Medica / Herbal Classics) because among all types of drugs, plant-based ones are the most numerous.
Old theories claim that the *Shennong Bencao Jing* (Divine Farmer's Materia Medica Classic) was authored by Shennong, but there is no definitive evidence for this, nor is it recorded in the *Han Shu: Yiwenzhi* (Book of Han: Treatise on Literature). The *Han Shu: Ji of Emperor Ping* records: "During the Yuanshi era, works on the Five Classics, Bencao, and medical arts amounted to several hundred thousand characters." The name "Bencao" likely appears here. However, the commentary by Li Shiji (Duke of Ying) et al., citing Ban Gu's preface to the *Huangdi Neijing* (Yellow Emperor's Inner Canon), states: "Based on the cold and warm properties of stones and herbs, one traces the depth of diseases." This is originally a discourse on classical prescriptions (Jingfang), not mentioning the term "Bencao." Only the Liang Dynasty's *Qilu* (Seven Records) records the *Shennong Bencao* in three volumes, promoting it as the beginning; this is considered an error. Some suspect that the counties and commanderies of origin recorded therein include place names from the Later Han Dynasty, suggesting it was written by figures like Zhang Zhongjing or Hua Tuo; this is also incorrect. The *Huainanzi* states: "Shennong tasted the flavors of a hundred herbs, suffering poison seventy times in a single day; thus, medical formulas arose." It seems that in ancient times, before the establishment of written texts, knowledge was transmitted orally from master to disciple, hence termed "Bencao." Since the Two Han Dynasties, the number of famous physicians increased. Figures such as Zhang Ji (Zhongjing) and Hua Tuo began based on ancient learning, attaching new theories, and compiling them systematically; thus, Bencao appeared in canonical catalogs. However, the old classic had only three volumes with merely 365 drugs. By the Liang Dynasty, Tao Hongjing (styled Ju Yin) presented the *Bielu* (Separate Record) of famous physicians, adding another 365 drugs, and annotated them, dividing the work into seven volumes. During the Xianqing era of the Tang Dynasty, Su Gong, the Supervisor of Guards and Longshi, collected errors and inaccuracies, submitting a memorial requesting revision. Consequently, Sikong and Duke of Ying, Li Shiji, were ordered to review gains and losses with Su Gong. They added 114 drugs, classified them into categories, and expanded the work to twenty volumes. The world calls this the *Tang Bencao* (Tang Materia Medica). In the Kaibao era of our dynasty, two edicts ordered medical officials Liu Han and Daoist Ma Zhi to compile and collect materials. They selected 133 drugs commonly used by physicians and proven effective, appending them. Imperial Academician Lu Duoxun, Li Fang, Wang You, Hu Meng, etc., were ordered to re-edit and revise, resulting in titles such as "Detailed Revision" and "Revised Edition," which were carved onto printing blocks and distributed. Thereafter, physicians knew what standards to follow. Meanwhile, Meng Chang of the pseudo-Shu state ordered his academician Han Baosheng et al. to compile a book referencing the Tang Bencao Tu Jing (Illustrated Classic of Materia Medica), making slight additions. The world calls this the *Shu Bencao* (Shu Materia Medica), which is also currently circulated. From the Han Dynasty to the present, barely a millennium has passed. Through three major compilations, over 600 drugs have been added, and collection has become extensive, making it quite comprehensive. Nevertheless, knowledgeable physicians still believe that due to its long circulation and subsequent scholarly research, many cross-references have accumulated; recent clinical usage reveals omissions and gaps. Therefore, a compilation and annotation are necessary to prepare for health preservation and disease eradication. In the eighth month of the Jiayou Second Year (1057), an edict instructed Ministers Yu Xi, Yi, Song, Dong, et al., to conduct further corrections. Having received the mandate, we conducted rigorous research. We privately opine that past physicians recorded treatments upon observing efficacy, leading to accumulation. Surveying various prescriptions, the volume is vast and difficult to exhaust; although repeatedly edited, criteria for inclusion and exclusion varied. Some drugs listed in the *Benjing* (Original Classic) are described briefly; some folk remedies are unknown to imperial physicians. If not detailedly recorded according to circumstances, many would be lost. Thus, we request to supplement and annotate based on existing omissions. We shall collect the functions of items recorded in various medical books and pharmacological spectra. However, names that are obscure, eccentric, or bizarre will be excluded. Regarding other historical and philosophical texts, even if not urgent for prescriptions, if they contain references where medicinal effects are verifiable and reliable, we shall also include them, striving for comprehensiveness to fulfill the imperial decree. Among various works titled "Bencao," we take the *Kaibao Chongding Bencao* (Kaibao Revised Materia Medica) as the standard. The distribution of volumes, the intermingling of classics and commentaries, and the use of vermilion and black ink follow old precedents without alteration. All supplements and annotations are based on cited books. If meanings duplicate old texts, they are deleted to avoid redundancy. If old texts exist but are incomplete, and later books elaborate, these are preserved in full for clarity and detail. Each entry begins with vermilion text stating: "We respectfully note according to [Book Name]..." For newly established entries, explanations appear at the end, citing "See [Book Name]." Cited sources prioritize the Tang and Shu Bencaos; others are ordered chronologically. When citing older Bencaos, we cite the author's name (e.g., "Person X says"); for Tang and Shu editions, we specify "Tang Bencao says" or "Shu Bencao says." Regarding ink colors: content from the *Shennong Benjing* is printed in vermilion; additions by famous physicians to Shennong's original entries are printed in black interspersed with vermilion; all other new additions are separate entries in black. Contributions by Tao Hongjing are termed *Mingyi Bie Lu* (Separate Record of Famous Physicians), with their notes attached at the end. Additions from the Xianqing era are noted at the end as "Tang Benxian Fu" (Previously Attached in Tang Edition). Additions from the Kaibao era are noted as "Jin Fu" (Currently Attached). New supplements absent from old classics are listed after each entry as "Xin Bu" (Newly Supplemented). Old classifications divided drugs into Upper, Middle, and Lower grades. The "New Supplements" are difficult to classify strictly, so they are attached by category, e.g., Lvfan (Green Alum) follows Fanshi (Alum), Shanjianghua (Mountain Ginger Flower) follows Doukou (Cardamom), Fusang follows Shuiyang, etc. If a drug's function is not in the *Benjing* but was cited in old notes, and current additions are similar, no new entry is made; instead, it is appended to the original note as "Xu Zhu" (Continued Note), e.g., Diyi (Lichen) attaches to Yuanyi (Wall Moss), Yanfu attaches to Tongcao, Mazao attaches to Haizao. Old notes from Tao are cited as "Tao Juanyin says"; those from Xianqing as "Tang Benzhu"; those from Kaibao as "Jinzhu"; specific Kaibao investigations are distinguished as "Jin An" (Current Examination), "Jin Xiang" (Current Detail), "You An" (Further Examination), marked in vermilion at the start. If a drug name exists in the *Benjing* but functions are incomplete, and current additions provide benefits, these are also appended to the original note. For drugs used in the current era but unrecorded in previous texts and lacking verification (e.g., Hulusba, Hindai/Kelp), we request deliberation among imperial physicians to establish new entries titled "Xin Ding" (Newly Determined). Total old drugs: 983; Newly supplemented: 82 (excluding those attached to notes); Newly determined: 17. Total new and old: 1,082 entries, roughly explained by category. These fifteen general principles reveal the intent of the supplementation. The prefaces by Kaibao, Ying Gong (Li Shiji), and Tao Shi (Tao Hongjing) contain valuable principles and cannot be omitted; they are retained in the first chapter.
Total New and Old Drugs: 1,082 Species
- 360 Species: Shennong Benjing (Divine Farmer's Original Classic)
- 182 Species: Mingyi Bie Lu (Separate Record of Famous Physicians)
- 114 Species: Tang Benxian Fu (Previously Attached in Tang Edition)
- 133 Species: Jin Fu (Currently Attached - Kaibao Addition)
- 194 Species: Youming Weiyong (Named but Unused)
- 82 Species: Xin Bu (Newly Supplemented)
- 17 Species: Xin Ding (Newly Determined)